Senior Research Associate
Joseph Nneji is a senior research associate at Verve Therapeutics, specializing in DNA, RNA and protein molecules. Prior to joining Verve, he held biochemical research positions at Arrakis Therapeutics and CRISPR Therapeutics. While at CRISPR Therapeutics, he conducted research on novel gene therapy treatments for sickle cell disease using CRISPR-Cas9 gene editing. Mr. Nneji received a B.S. in biochemistry from Northeastern University.